Ascendis Pharma A (ASND) Change in Inventory (2021 - 2026)

Ascendis Pharma A has disclosed Change in Inventory across 6 years of filings, most recently posting $368.0 million for Q1 2026.

• Change in Inventory for Q1 2026 came in at $368.0 million, up 13684.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $368.0 million (up 664.87% YoY), and the FY2025 annual result was $351.0 million, up 11.12% from the prior year.
• Change in Inventory came in at $368.0 million for Q1 2026 at Ascendis Pharma A, up from $583185.8 in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $368.0 million in Q1 2026 to a low of -$32.2 million in Q4 2024.
• The 5-year median for Change in Inventory is -$18.6 million (2023), against an average of $48.9 million.
• Across the five-year window, Change in Inventory tumbled 762.95% in 2023 and soared 13684.95% in 2026, its largest moves.
• Ascendis Pharma A's Change in Inventory stood at -$27.2 million in 2022, then gained by 21.79% to -$21.3 million in 2023, then slumped by 51.37% to -$32.2 million in 2024, then jumped by 101.81% to $583185.8 in 2025, then surged by 63004.16% to $368.0 million in 2026.
• The last three Change in Inventory figures came in at $368.0 million (Q1 2026), $583185.8 (Q4 2025), and $353.1 million (Q3 2025), per Business Quant data.